These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18939494)

  • 1. [Mathematic modeling for prediction of waning immunity and timing of booster doses].
    Matuo F; Okada K
    Nihon Rinsho; 2008 Oct; 66(10):1944-9. PubMed ID: 18939494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of immunity level against diphtheria and reinforcement of immunity by booster vaccination for infection control staff in Okayama prefecture.
    Nakajima H; Kariya H; Ohata R; Ogura H
    Jpn J Infect Dis; 2008 Mar; 61(2):104-6. PubMed ID: 18362396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
    Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives.
    Gomes MG; White LJ; Medley GF
    J Theor Biol; 2004 Jun; 228(4):539-49. PubMed ID: 15178201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization glossary.
    Ofosu-amaah S; Shah KP
    Assignment Child; 1985; (69-72):455-62. PubMed ID: 12340732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
    Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
    Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.